| P50 | author | Farzan Sasangohar | Q85220368 |
| | Katherine H. Chan | Q87140081 |
| P2093 | author name string | Anthony Easty | |
| | Patricia Trbovich | |
| | Christine Koczmara | |
| | Christopher Colvin | |
| | Mark Fan | |
| | Caterina Masino | |
| | Sonia Pinkney | |
| P2860 | cites work | Infusion pump integration | Q95410913 |
| | The Critical Care Safety Study: the incidence and nature of adverse events and serious medical errors in intensive care | Q24266838 |
| | Discretionary task interleaving: heuristics for time allocation in cognitive foraging | Q28240580 |
| | A critical examination of high-fidelity human patient simulation within the context of nursing pedagogy. | Q30373926 |
| | Using failure mode and effects analysis to plan implementation of smart i.v. pump technology | Q33253285 |
| | Analysis of risk factors for adverse drug events in critically ill patients*. | Q33397860 |
| | Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial. | Q33750788 |
| | Infusion set characteristics such as antireflux valve and dead-space volume affect drug delivery: an experimental study designed to enhance infusion sets | Q34151760 |
| | The impact of traditional and smart pump infusion technology on nurse medication administration performance in a simulated inpatient unit | Q34289205 |
| | A review of human factors principles for the design and implementation of medication safety alerts in clinical information systems. | Q34371903 |
| | Causes of intravenous medication errors: an ethnographic study | Q35526622 |
| | Insights from the sharp end of intravenous medication errors: implications for infusion pump technology | Q35527447 |
| | Medication errors in intravenous drug preparation and administration: a multicentre audit in the UK, Germany and France | Q35527808 |
| | Multiple intravenous infusions phase 1b: practice and training scan | Q36040223 |
| | Programmable infusion pumps in ICUs: an analysis of corresponding adverse drug events | Q36293570 |
| | An overview of intravenous-related medication administration errors as reported to MEDMARX, a national medication error-reporting program | Q36374861 |
| | Taking aim at infusion confusion | Q36422748 |
| | A concept analysis of the phenomenon interruption | Q36735306 |
| | Nurses relate the contributing factors involved in medication errors | Q36750208 |
| | Peripheral line dead space: an unrecognised phenomenon? | Q37138632 |
| | Smart infusion technology: a minimum safety standard for intensive care? | Q37194444 |
| | The effects of acute stress on performance: implications for health professions education | Q37631417 |
| | Critical parameters in drug delivery by intravenous infusion | Q38097084 |
| | Standard drug concentrations and smart-pump technology reduce continuous-medication-infusion errors in pediatric patients | Q38473264 |
| | Communication loads on clinical staff in the emergency department | Q39605164 |
| | Ethnographic study of incidence and severity of intravenous drug errors. | Q39742759 |
| | The link between intravenous multiple pump flow errors and infusion system mechanical compliance | Q39889401 |
| | The delivery of drugs to patients by continuous intravenous infusion: modeling predicts potential dose fluctuations depending on flow rates and infusion system dead volume | Q40341066 |
| | Errors Associated with IV Infusions in Critical Care | Q41262761 |
| | Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units | Q41575106 |
| | Combating omission errors through task analysis and good reminders | Q41838281 |
| | Crisis management during anaesthesia: vascular access problems | Q42022235 |
| | Intravenous medication administration in intensive care: opportunities for technological solutions. | Q43162581 |
| | Impact of multiaccess infusion devices on in vitro drug delivery during multi-infusion therapy | Q43275094 |
| | Connecting multiple low-flow intravenous infusions in the newborn: problems and possible solutions | Q44632931 |
| | The impact of multilumen infusion devices on the occurrence of known physical drug incompatibility: a controlled in vitro study. | Q46455749 |
| | Variability in intravenous medication practices: implications for medication safety | Q46506754 |
| | Errors in preparation and administration of intravenous medications in the intensive care unit of a teaching hospital: an observational study. | Q46665088 |
| | The checklist: if something so simple can transform intensive care, what else can it do? | Q48022760 |
| | Quantitative analysis of continuous intravenous infusions in pediatric anesthesia: safety implications of dead volume, flow rates, and fluid delivery | Q48305099 |
| | An in vitro analysis of central venous drug delivery by continuous infusion: the effect of manifold design and port selection | Q48401403 |
| | An analysis of drug delivery dynamics via a pediatric central venous infusion system: quantification of delays in achieving intended doses | Q48406852 |
| | Central venous catheter infusions: a laboratory model shows large differences in drug delivery dynamics related to catheter dead volume | Q48537885 |
| | The impact of carrier flow rate and infusion set dead-volume on the dynamics of intravenous drug delivery. | Q50485502 |
| | Patient transfer; what to do about the 'spaghetti'. | Q51583917 |
| | Use of colour-coded labels for intravenous high-risk medications and lines to improve patient safety. | Q51796655 |
| | Relationship among subjective mental workload, experience, and education of cardiovascular critical care RNs. | Q52031014 |
| | Presidential address: take ownership | Q52913084 |
| | A comparison of voluntarily reported medication errors in intensive care and general care units | Q59652647 |
| | Users as designers: how people cope with poor HCI design in computer-based medical devices | Q71928086 |
| | Continous intravenous infusion and multicompartment accumulation | Q72223332 |
| | Strangulation with intravenous tubing: a previously undescribed adverse advent in children | Q73459392 |
| | Measuring organizational traits of hospitals: the Revised Nursing Work Index | Q73959074 |
| | Medication errors involving continuously infused medications in a surgical intensive care unit | Q75393875 |
| | Right programming of pumps to prevent errors in the infusion process | Q78797035 |
| | Avoiding disastrous outcomes with rapid intravenous push medications | Q80796243 |
| | Flushing an i.v. line: a simple but potentially costly procedure for both patient and health unit | Q81026259 |
| | Implementation of an i.v. medication safety system | Q81474491 |
| | "Smart" infusion pumps are selectively intelligent | Q83422396 |
| | Interruptions during the delivery of high-risk medications | Q84134957 |
| | Intermittent I.V. infusions in acute care: special considerations | Q85503625 |
| | Which smart pumps are smartest? | Q86209590 |
| | The effects of interruptions on oncologists' patient assessment and medication ordering practices | Q86412316 |
| P433 | issue | 5 | |
| P304 | page(s) | 1-163 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | Ontario health technology assessment series | Q27722839 |
| P1476 | title | Multiple Intravenous Infusions Phase 2b: Laboratory Study | |
| P478 | volume | 14 | |